HTL Biotechnology inaugurates a new production line dedicated to sterile Hyaluronic Acid
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.
Press releases
June 5, 2025
HTL Biotechnology inaugurates a new production line dedicated to sterile Hyaluronic Acid
On the occasion of National Bioproduction and Biomedicines Day (JNBB), which enjoys the high patronage of the President of the French Republic, HTL Biotechnology confirms its position as a global leader in the development and production of pharmaceutical-grade biopolymers, by inaugurating a new production unit dedicated to sterile hyaluronic acid at its Javené (Ille-et-Vilaine) site, a true flagship of French biomanufacturing.
To see our most recent news,
follow us on LinkedIn
Read more
news from us
-
Articles September 13, 2025Looking Back at Our Presence at ESCRS 2025
The European Society of Cataract and Refractive Surgeons (ESCRS) is a unique opportunity each year to connect with our clients and partners while gaining insights into the key trends shaping the future of ophthalmology.
-
Articles July 23, 20252024 CSR Report is now available!
We’re pleased to share our second CSR report, highlighting the actions and commitments we carried out throughout 2024.
-
Articles June 12, 2025Strong Presence at ISHAS Congress 2025 in the USA
A Global Scientific Gathering Dedicated to Hyaluronic Acid Innovation.